This is why Amanda Oliver, 31, a career consultant in Charleston, SC, pops a CBD gummy bear each night before bed. “I used to lie there tossing and turning as my mind raced from work projects to whether I had set the home alarm,” Oliver says. One piece of candy with 15 milligrams (mg) of CBD is enough to shut off her brain and facilitate sleep. She also swears by the CBD oil she takes at the height of her period, which she says quells her debilitating cramps.
The endocannabinoid system is spread throughout your brain and body, but primarily throughout your central nervous system. The interaction between cannabinoids and receptors is what produces effects like the regulation of mood, pain, appetite, inflammation, and memory. Plant-based cannabinoids, found in cannabis plants, also interact with the receptors (whimsically named CB1 and CB2) in the endocannabinoid system, and each affects your body in different ways. CBD and its infamous cousin THC are the 2 most well-known cannabinoids.
CBD is a compound that can be found in cannabis plants. While CBD is an ingredient in marijuana, CBD oil can typically have the health benefits of marijuana without the psychoactive effects that THC cause. If you live in a state where CBD oil is legal and you’re hoping to reap the potential health benefits of marijuana without getting high, CBD oil might be for you. Choose from a variety of ways to consume it and experiment with dosages until you find the right one. Try using CBD oil to naturally relieve pain, reduce anxiety, and improve your overall well being.
Cannabidiol hemp oil, or CBD hemp oil, is made from high-CBD and low-THC hemp, unlike medical marijuana derivatives that often contain high quantities of tetrahydrocannabinol (THC). CBD hemp oil, a natural botanical extract of the common hemp plant, is therefore non-psychoactive. And, whereas in the cannabis plant CBD is the second most abundant cannabinoid after THC; in hemp it dominates the cannabinoid makeup, as THC is found only in trace amounts. CBD’s myriad of health benefits, however, are still present.
CBD works by attaching itself to specific receptors of the body’s own endocannabinoid system. The human body is known to produce cannabinoids of its own, which affect the cannabinoid receptors CB1 and CB2. The CB1 receptors are generally found in the brain, and deal with pain, mood and emotions, movement, appetite, among others. THC acts upon the CB1 receptors. Meanwhile, CB2 receptors are more commonly found throughout the immune system, affecting inflammation and thus pain. CBD is thought to act upon these receptors, by influencing the body to produce its own cannabinoids in order to rebalance itself.
Hemp Bombs offers high-strength CBD in the following concentrations: 1000mg, 2000mg, and an *insane* 4000mg. This is in addition to their regular strength products (75mg, 250mg, 300mg). These high-strength CBD oils are available as either flavored e-liquid or a flavorless tank additive if you already have an e-juice flavor that you love. If you’re the type of person who needs a high strength product to feel the effects, the 4000mg bottle of e-liquid will be perfect for you. It costs a pretty penny but it lasts an incredibly long time.
Non-THC CBD oils can be highly effective, and are suitable for employees who face random or routine drug tests. Our top pick for this category is the Medterra CBD Oil Tincture, which contains 99.6% CBD and MCT oil (also known as coconut oil extract) without any traces of THC. The oil is derived from hemp plants that are free of GMOs and pesticides, as well. All third-party testing results for the oil are accessible through Medterra’s official product page.
A study from 2016 worked with 214 people with epilepsy. The study participants added oral doses of 2 to 5mg of CBD per day to their existing anti-epilepsy medications. The study’s researchers monitored the participants for 12 weeks, recording any negative side effects and checking on the frequency of their seizures. Overall, participants had 36.5 percent fewer seizures per month. However, severe adverse effects were recorded in 12 percent of the participants.